Results 151 to 160 of about 20,735 (212)

Immune Response to COVID-19 Vaccines: Updates in a Fast-Moving Scenario. [PDF]

Vaccines (Basel)
De Marco F.
europepmc   +1 more source

Adenoviral Inciting Antigen and Somatic Hypermutation in VITT. [PDF]

N Engl J Med
Wang JJ, Schönborn L, Warkentin TE, Müller L, Thiele T, Ulm L, Völker U, Ameling S, Franzenburg S, Kaderali L, Tzvetkova A, Colella A, Chataway T, Tan CW, Armour B, Troelnikov A, Rutten L, McCluskey J, Zahn R, Gordon TP, Greinacher A.   +20 more
europepmc   +1 more source

Association between nucleic acid COVID-19 vaccines and acute myocardial infarction in adults: a systematic review. [PDF]

Front Cardiovasc Med
Castellanos-Hernández DI, Mayoral-Chávez MA, Matias-Cervantes CA, Alpuche J.   +3 more
europepmc   +1 more source

African swine fever virus genes vectored by simian adenoviruses do not protect against virulent genotype II virus challenge. [PDF]

Microbiol Spectr
Tng PYL, Al-Adwani L, Goatley LC, Loundras E-A, Powers C, Netherton CL.   +5 more
europepmc   +1 more source

Impact of maintenance immunosuppression regimen on anti-SARS-CoV-2 antibody and cellular kinetics in kidney transplant recipients receiving ChAdOx1 as primary vaccination. [PDF]

Braz J Infect Dis
Reis JS, Souza RM, Tedesco-Silva H, Requião-Moura L, Pestana JM, Foresto RD.   +5 more
europepmc   +1 more source

Building better antibody responses: The interplay of infection, vaccination, and immune imprinting. [PDF]

PNAS Nexus
Carissa Aurelia L, Selva KJ, Chung AW.
europepmc   +1 more source

Primary and Booster COVID-19 Vaccination in Patients with Sjögren's Disease: Data from the Longitudinal SAFER Cohort Study. [PDF]

Vaccines (Basel)
Barbosa Beloni Lirio M, Machado KLLL, Assis Martins-Filho O, Miyamoto ST, Gurtler Pinheiro de Oliveira Y, Vieira Serrano É, Geraldo Mill J, Rosemarie Lallemand Tapia K, Baptista Ferreira L, Ribeiro de Oliveira J, Gouvea MDPG, Rodrigues Aguiar LG, Souza BO, Cruz VA, Xavier RM, Teixeira Carvalho A, de Souza VA, Ferreira GA, Monticielo OA, Neto ETDR, Sato EI, Pileggi GS, Valim V.   +22 more
europepmc   +1 more source

Heterologous Prime-Boost with ChAdOx1-VZV Establishes Dual-Layer Immunogenicity Conferring Protective Potential Against Herpes Zoster. [PDF]

Vaccines (Basel)
Zhao J, Shao J, Sui X, Wei M, Ma X, Xu Z, Zhu T.   +6 more
europepmc   +1 more source

Immune responses after two inactivated COVID-19 vaccine doses, a heterologous third dose and subsequent boosting with bivalent mRNA in adults. [PDF]

Sci Rep
Muangnoicharoen S, Lawpoolsri S, Cowan J, Luvira V, Jongkaewwattana A, Nanthapisal S, Phumratanaprapin W, Kamolratanakul S, Thanthamnu N, Duangdee C, Pitisuttithum P.   +10 more
europepmc   +1 more source

Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose [PDF]

Atzori, Luigi, Campagna, Marcello, Caria, Paola, Chessa, Luchino, Coghe, Ferdinando, Costanzo, Giulia, Firinu, Davide, Galdiero, Massimiliano, Littera, Roberto, Manzin, Aldo, Marongiu, Alessandra, Palmas, Vanessa, Perra, Andrea, Piras, Cristina, Sanna, Giuseppina   +14 more
core   +1 more source